USPTO serial 79336403
CUVUE ORPHALAN
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 20, 2022
- Examiner
- GALANTE, JOSHUA MICHAEL
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with CUVUE ORPHALAN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Heather Smith-Carra
Heather Smith-Carra Banner & Witcoff, Ltd.1100 13th Street NWSuite 1200Washington, DC 20005Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of Wilson's disease; pharmaceutical products for the treatment of Wilson's disease; chemical preparations for medical purposes, namely, for treatment of Wilson's disease; chemical preparations for pharmaceutical purposes, namely, for treatment of Wilson's disease; medicinal substances, namely, therapeutic medication for the treatment of Wilson's disease; medicinal preparations for the treatment of Wilson's disease; chemical preparations for medical or pharmaceutical use for the treatment of Wilson's disease; pharmaceutical products and medicines for the treatment of Wilson's disease; pharmaceutical preparations for the diagnosis of Wilson disease; pharmaceutical and chemical preparations for medical purposes, namely, for copper level measurement for the diagnosis and treatment of Wilson's disease; chemical reagents for medical purposes; chemical reagents for medical diagnostic purposes in patients with Wilson's disease; pre-filled syringes sold filled with pharmaceuticals for medical purposes for the diagnosis and treatment of Wilson's disease; medicated serums for diagnostic purposes, specifically, for the treatment of Wilson's disease; biological preparations for medical purposes for the treatment of Wilson's disease, specifically, for the measurement of copper in patients with Wilson's disease; chemical preparations for medical purposes for the measurement of copper in patients with Wilson's disease; clinical diagnostic reagents for medical use; diagnostic preparations for medical purposes for treatment of Wilson's disease; medical diagnostic reagents and assays for testing of body fluids to diagnose the level of copper | ACTIVE | — |
| 044 | Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical analysis services relating to the treatment of persons, namely diagnosis of copper levels in patients with Wilson's disease; medical screening; health care for patients with Wilson's disease; health assessment services care for patients with Wilson's disease; home-visit nursing care; medical services, namely, blood testing services provided by medical laboratories for patients with Wilson's disease; medical clinic services and medical analysis services provided by medical laboratories for diagnostic purposes for patients with Wilson's disease; medical analysis services provided by medical laboratories for diagnostic purposes to measure copper levels in patients with Wilson's disease; medical diagnostic testing, monitoring and reporting services for patients with Wilson's disease; medical testing for diagnostic or treatment purposes in the field of Wilson's disease | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 25, 2023 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 5, 2023 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Apr 5, 2023 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Mar 20, 2023 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 20, 2022 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Dec 20, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 4, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 4, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 3, 2022 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Sep 14, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Sep 14, 2022 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Sep 14, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 26, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 25, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 25, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 25, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 23, 2022 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 4, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 4, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 19, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 18, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 8, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 29, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 25, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 24, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |